Cold Spring Harbor Library  CSHL: Home
   Home       Services       Archives       About Us   
 
CSHL Publication List
CSHL Authors Publications
Go back to Search Mode

          
Sort by   in order
19 Article(s) on File
Page 1 of 1
A Unified Nomenclature and Amino Acid Numbering for Human PTEN
Pulido R,
Baker SJ,
Barata JT,
Carracedo A,
Cid VJ,
Chin-Sang ID,
Dave V,
den Hertog J,
Devreotes P,
Eickholt BJ,
Eng C,
Furnari FB,
Georgescu MM,
Gericke A,
Hopkins B,
Jiang X,
Lee SR,
Losche M,
Malaney P,
Matias-Guiu X,
Molina M,
Pandolfi PP,
Parsons R,
Pinton P,
Rivas C,
Rocha RM,
Rodriguez MS,
Ross AH,
Serrano M,
Stambolic V,
Stiles B,
Suzuki A,
Tan SS,
Tonks NK,
Trotman LC,
Wolff N,
Woscholski R,
Wu H,
Leslie NR

Science signaling
  7 (332): pe15; Jul 1 2014   Nlm
[Abstract]
[DOI] [Full Text]

DOK2 inhibits EGFR-mutated lung adenocarcinoma
Berger AH,
Chen M,
Morotti A,
Janas JA,
Niki M,
Bronson RT,
Taylor BS,
Ladanyi M,
Van Aelst L,
Politi K,
Varmus HE,
Pandolfi PP

PLoS One
  8 (11): e79526; 2013   Nlm
[Abstract]
[DOI] [Full Text]

Subtle variations in Pten dose determine cancer susceptibility
Alimonti A,
Carracedo A,
Clohessy JG,
Trotman LC,
Nardella C,
Egia A,
Salmena L,
Sampieri K,
Haveman WJ,
Brogi E,
Richardson AL,
Zhang J,
Pandolfi PP

Nature Genetics
  42 (5): 454-458; May 2010   PMC3118559
[Abstract]
[DOI] [Full Text] [PDF]

A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis
Alimonti A,
Nardella C,
Chen Z,
Clohessy JG,
Carracedo A,
Trotman LC,
Cheng K,
Varmeh S,
Kozma SC,
Thomas G,
Rosivatz E,
Woscholski R,
Cognetti F,
Scher HI,
Pandolfi PP

Journal of Clinical Investigation
  120 (3): 681-693; Mar 2010  
[Abstract]
[DOI] [Full Text]

The Effect of Deleting p110{delta} on the Phenotype and Function of PTEN-Deficient B Cells
Janas ML,
Hodson D,
Stamataki Z,
Hill S,
Welch K,
Gambardella L,
Trotman LC,
Pandolfi PP,
Vigorito E,
Turner M

J Immunol
  180 (2): 739-46; Jan 15 2008  
[Abstract]
[Full Text] [PDF]

Ubiquitination regulates PTEN nuclear import and tumor suppression
Trotman LC,
Wang X,
Alimonti A,
Chen Z,
Teruya-Feldstein J,
Yang H,
Pavletich NP,
Carver BS,
Cordon-Cardo C,
Erdjument-Bromage H,
Tempst P,
Chi SG,
Kim HJ,
Misteli T,
Jiang X,
Pandolfi PP

Cell
  128 (1): 141-56; Jan 12 2007   PMCID: PMC1855245
[Abstract]
[DOI] [Full Text] [PDF]

NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN
Wang X,
Trotman LC,
Koppie T,
Alimonti A,
Chen Z,
Gao Z,
Wang J,
Erdjument-Bromage H,
Tempst P,
Cordon-Cardo C,
Pandolfi PP,
Jiang X

Cell
  128 (1): 129-139; Jan 2007  
[Abstract]
[DOI] [Full Text]

Identification of a tumour suppressor network opposing nuclear Akt function
Trotman LC,
Alimonti A,
Scaglioni PP,
Koutcher JA,
Cordon-Cardo C,
Pandolfi PP

Nature
  441 (7092): 523-527; May 25 2006  
[Abstract]
[DOI] [Full Text]

Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis
Zhao M,
Janas JA,
Niki M,
Pandolfi PP,
Van Aelst L

Mol Cell Biol
  26 (7): 2479-89; Apr 2006  
[Abstract]
[DOI] [Full Text] [PDF]

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen Z,
Trotman LC,
Shaffer D,
Lin HK,
Dotan ZA,
Niki M,
Koutcher JA,
Scher HI,
Ludwig T,
Gerald W,
Cordon-Cardo C,
Pandolfi PP

Nature
  436 (7051): 725-30; Aug 4 2005   NLM
[Abstract]
[DOI] [Full Text]

Role of Dok-1 and Dok-2 in leukemia suppression
Niki M,
Di Cristofano A,
Zhao M,
Honda H,
Hirai H,
Van Aelst L,
Cordon-Cardo C,
Pandolfi PP

J Exp Med
  200 (12): 1689-95; Dec 20 2004   PMCID: PMC2211998
[Abstract]
[DOI] [Full Text] [PDF]

SUMO Modification of Huntingtin and Huntingtons Disease Pathology
Steffan JS,
Agrawal N,
Pallos J,
Rockabrand E,
Trotman LC,
Slepko N,
Illes K,
Lukacsovich T,
Zhu YZ,
Cattaneo E,
Pandolfi PP,
Thompson LM,
Marsh JL

Science
  304 (5667): 100-104; Apr 2 2004  
[Abstract]
[DOI]

PML is a direct p53 target that modulates p53 effector functions
de Stanchina E,
Querido E,
Narita M,
Davuluri RV,
Pandolfi PP,
Ferbeyre G,
Lowe SW

Mol Cell
  13 (4): 523-35; Feb 27 2004  
[Abstract]
[DOI] [Full Text]

Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors
Ruzinova MB,
Schoer RA,
Gerald W,
Egan JE,
Pandolfi PP,
Rafii S,
Manova K,
Mittal V,
Benezra R

Cancer Cell
  4 (4): 277-289; Oct 2003  
[Abstract]
[Full Text]

PTEN and p53: who will get the upper hand?
Trotman LC,
Pandolfi PP

Cancer Cell
  3 (2): 97-9; Feb 2003   NLM
[Full Text]

Pten dose dictates cancer progression in the prostate
Trotman LC,
Niki M,
Dotan ZA,
Koutcher JA,
Di Cristofano A,
Xiao A,
Khoo AS,
Roy-Burman P,
Greenberg NM,
Van Dyke T,
Cordon-Cardo C,
Pandolfi PP

Plos Biology
  1 (3): 2003  
[Abstract]
[DOI] [Full Text]

p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl)
Di Cristofano A,
Niki M,
Zhao MM,
Karnell FG,
Clarkson B,
Pear WS,
Van Aelst L,
Pandolfi PP

Journal of Experimental Medicine
  194 (3): 275-284; Aug 2001   PMCID: PMC2193466
[Abstract]
[DOI] [Full Text] [PDF]

Phosphoinositide 3-kinase-dependent membrane recruitment of p62(dok) is essential for its negative effect on mitogen-activated protein (MAP) kinase activation
Zhao MM,
Schmitz AA,
Qin Y,
Di Cristofano A,
Pandolfi PP,
Van Aelst L

Journal of Experimental Medicine
  194 (3): 265-274; Aug 2001   PMCID: PMC2193463
[Abstract]
[Full Text] [PDF]

Role of p65(dok) in leukemogenesis by p210(bcr-abl)
Niki M,
Di Cristofano A,
Zhao M,
Karnell FG,
Clarkson B,
Pear WS,
Van Aelst L,
Pandolfi PP

Blood
  96 (11): 510A-510A; Nov 2000  



Page 1 of 1

Go back to Search Mode


Last Updated: September, 2017
Most Recent Publications: Jan 13, 2015

© 2012   CSHL Library and Archives   1 Bungtown Rd.   Cold Spring Harbor, NY 11724   Library Information 516-367-6872
CSHL Home Intranet